MXPA05009014A - Antagonistas del receptor ccr-3. - Google Patents

Antagonistas del receptor ccr-3.

Info

Publication number
MXPA05009014A
MXPA05009014A MXPA05009014A MXPA05009014A MXPA05009014A MX PA05009014 A MXPA05009014 A MX PA05009014A MX PA05009014 A MXPA05009014 A MX PA05009014A MX PA05009014 A MXPA05009014 A MX PA05009014A MX PA05009014 A MXPA05009014 A MX PA05009014A
Authority
MX
Mexico
Prior art keywords
ccr
receptor antagonists
compounds
arl
useful
Prior art date
Application number
MXPA05009014A
Other languages
English (en)
Inventor
Gong Leyi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA05009014A publication Critical patent/MXPA05009014A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a compuestos de la formula (I): (ver formula (I)) en donde: Ar, Ar1, R3-R5, E, F, T, Q y m son como se definio en la descripcion. Los compuestos son utiles como antagonistas del receptor CCR-3, y por lo tanto pueden usarse para el tratamiento de enfermedades mediadas por CCR-3.
MXPA05009014A 2003-02-27 2004-02-19 Antagonistas del receptor ccr-3. MXPA05009014A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45038003P 2003-02-27 2003-02-27
PCT/EP2004/001588 WO2004076448A1 (en) 2003-02-27 2004-02-19 Ccr-3 receptor antagonists

Publications (1)

Publication Number Publication Date
MXPA05009014A true MXPA05009014A (es) 2005-10-18

Family

ID=32927646

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009014A MXPA05009014A (es) 2003-02-27 2004-02-19 Antagonistas del receptor ccr-3.

Country Status (12)

Country Link
US (3) US7081531B2 (es)
EP (1) EP1599472A1 (es)
JP (1) JP2006515340A (es)
KR (1) KR20050113202A (es)
CN (1) CN1753891A (es)
AU (1) AU2004215679A1 (es)
BR (1) BRPI0407913A (es)
CA (1) CA2516634A1 (es)
MX (1) MXPA05009014A (es)
PL (1) PL378753A1 (es)
RU (1) RU2005129550A (es)
WO (1) WO2004076448A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
WO2007034252A1 (en) * 2005-09-22 2007-03-29 Sanofi-Aventis Amino-alkyl-amide derivatives as ccr3 receptor liquids
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
JPWO2009101917A1 (ja) * 2008-02-13 2011-06-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビシクロアミン誘導体
HUP0800478A2 (en) * 2008-07-31 2010-03-01 Sanofi Aventis Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
EP2393804B1 (en) 2009-02-06 2014-04-16 Janssen Pharmaceuticals, Inc. Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
US8835482B2 (en) 2009-05-07 2014-09-16 Janssen Pharmaceuticals, Inc. Substituted indazole and aza-indazole derivatives as gamma secretase modulators
US8946266B2 (en) 2009-07-15 2015-02-03 Janssen Pharmaceuticals, Inc. Substituted triazole and imidazole derivatives as gamma secretase modulators
CN102906083A (zh) 2010-01-15 2013-01-30 杨森制药公司 作为γ分泌酶调节剂的新的取代的三唑衍生物
JP2014508794A (ja) 2011-03-24 2014-04-10 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド γ−セクレターゼ調節剤としての新規な置換トリアゾリルピペラジンおよびトリアゾリルピペラジン誘導体
EA023045B1 (ru) 2011-07-15 2016-04-29 Янссен Фармасьютикалз, Инк. Новые замещенные производные индола в качестве модуляторов гамма-секретазы
JP6106745B2 (ja) 2012-05-16 2017-04-05 ヤンセン ファーマシューティカルズ，インコーポレーテッド （特に）アルツハイマー病の治療に有用な置換３，４−ジヒドロ−２Ｈ−ピリド［１，２−ａ］ピラジン−１，６−ジオン誘導体
CN104918938B (zh) 2012-12-20 2017-08-15 詹森药业有限公司 新颖的作为γ分泌酶调节剂的三环3，4‑二氢‑2H‑吡啶并[1，2‑a]吡嗪‑1，6‑二酮衍生物
EP2945944B1 (en) 2013-01-17 2016-11-09 Janssen Pharmaceutica, N.V. Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
ES2764840T3 (es) 2015-01-28 2020-06-04 Univ Bordeaux Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
US4366154A (en) * 1981-11-09 1982-12-28 Sandoz, Inc. Tropyl derivatives
WO1994022846A1 (en) 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
CA2350722A1 (en) * 1998-11-17 2000-05-25 Leyi Gong 4-aroyl-piperidin-ccr-3 receptor antagonists iii
EP1131290B1 (en) 1998-11-20 2008-02-20 F. Hoffmann-La Roche Ag Piperidine ccr-3 receptor antagonists
US6331541B1 (en) * 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6586446B1 (en) * 1999-10-15 2003-07-01 Bristol-Myers Squibb Company Bicyclic and tricyclic amines as modulators of chemokine receptor activity
WO2002026708A1 (fr) * 2000-09-27 2002-04-04 Toray Industries, Inc. Composes conenant de l'azote et inhibiteurs de ccr3 contenant ces composes en tant que principe actif

Also Published As

Publication number Publication date
US20040176416A1 (en) 2004-09-09
US7081531B2 (en) 2006-07-25
US20060194790A1 (en) 2006-08-31
BRPI0407913A (pt) 2006-03-01
EP1599472A1 (en) 2005-11-30
US20060189596A1 (en) 2006-08-24
RU2005129550A (ru) 2006-07-27
CA2516634A1 (en) 2004-09-10
WO2004076448A1 (en) 2004-09-10
CN1753891A (zh) 2006-03-29
KR20050113202A (ko) 2005-12-01
JP2006515340A (ja) 2006-05-25
AU2004215679A1 (en) 2004-09-10
PL378753A1 (pl) 2006-05-15

Similar Documents

Publication Publication Date Title
MXPA05009014A (es) Antagonistas del receptor ccr-3.
HK1096673A1 (en) Compositions useful as inhibitors of protein kinases
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
HK1113569A1 (en) Pyrazolo
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
TW200633980A (en) Pyridones useful as inhibitors of kinases
NO20055741D0 (no) Nye kjemiske forbindelser
DE602004011394D1 (en) Thiazolderivate
UA84930C2 (ru) Пиррольные соединения как ингибиторы протеинкиназ erk, их синтез и соответствующие промежуточные соединения
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
IL200793A0 (en) Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases
TW200740787A (en) (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
MX2010003866A (es) Heteroaril amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
WO2005075450A3 (en) Spiro-benzodioxoles and their use as cb1 antagonists
TW200745088A (en) Benzimidazoles useful as inhibitors of protein kinases
UA87494C2 (en) Azaindoles useful as inhibitors of jak and other protein kinases
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MY141020A (en) Novel pparalpha and ppargamma agonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal